Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD 08/14/2018 Medications, LIVONIA, Mich., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage...